Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study.
J Cancer Res Clin Oncol. 2023 Nov;149(17):15827-15838. doi: 10.1007/s00432-023-05339-0. Epub 2023 Sep 6.
J Cancer Res Clin Oncol. 2023.
PMID: 37672075
Free PMC article.
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1.
Pan Y, Shu G, Fu L, Huang K, Zhou X, Gui C, Liu H, Jin X, Chen M, Li P, Cen J, Feng Z, Lu J, Chen Z, Li J, Xu Q, Wang Y, Liang H, Wang Z, Deng Q, Chen W, Luo J, Yang J, Zhang J, Wei J.
Pan Y, et al.
Adv Sci (Weinh). 2023 Apr;10(11):e2206792. doi: 10.1002/advs.202206792. Epub 2023 Feb 12.
Adv Sci (Weinh). 2023.
PMID: 36775874
Free PMC article.
Item in Clipboard
DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC.
Wei J, Lu J, Cao Y, Yao G, Huang Y, Zhao H, Pan Y, Feng Z, Chen Z, Chen W, Luo J, Cao J.
Wei J, et al.
Curr Cancer Drug Targets. 2021;21(10):849-859. doi: 10.2174/1568009621666210811115054.
Curr Cancer Drug Targets. 2021.
PMID: 34382524
Item in Clipboard
Cite
Cite